Dandan Wang et al. BTS 2018;3:350-362 Overexpression of miR-24 Ameliorates Diabetic Ischemia/Reperfusion Injury (A) Schematic protocol of miR-24 delivery.

Slides:

Advertisements

Similar presentations

Yan Wu, Xiangru Lu, Fuli Xiang, and Qingping Feng

Advertisements

Tumor necrosis factor-α does not modulate ischemia/reperfusion injury in naïve myocardium but is essential for the development of late preconditioning

Cardioprotective Effect of a Hemoglobin-Based Oxygen Carrier on Cold Ischemia/Reperfusion Injury Cardiology 2011;120:73–83 - DOI: / Fig.

Circ Cardiovasc Interv

Transforming Growth Factor‐β Receptor III is a Potential Regulator of Ischemia‐Induced Cardiomyocyte Apoptosis by Fei Sun, Xin Li, Wen‐Qi Duan, Wei Tian,

Activation of Liver-X-Receptor α But Not Liver-X-Receptor β Protects Against Myocardial Ischemia/Reperfusion InjuryCLINICAL PERSPECTIVE by Qing He, Jun.

Central role of Sp1-regulated CD39 in hypoxia/ischemia protection

Simvastatin attenuates cardiac isograft ischemia-reperfusion injury by down-regulating CC chemokine receptor-2 expression Rong Yin, MD, Jiaquan Zhu,

Muhammad Ali et al. BTS 2016;1:

by Simon F. De Meyer, Alexander S. Savchenko, Michael S

Céline Jumeau et al. BTS 2016;j.jacbts

Cyclophosphamide protects against myocardial ischemia/reperfusion injury in rats: One of the therapeutic targets is high sensitivity C-reactive protein

Molecular Therapy - Nucleic Acids

Volume 75, Issue 2, Pages (January 2009)

Isaac Perea-Gil et al. BTS 2016;1:

The Journal of Thoracic and Cardiovascular Surgery

Hui-Fang Song et al. BTS 2017;2:

Hui-Fang Song et al. BTS 2017;2:

Nat. Rev. Cardiol. doi: /nrcardio

Lukas J. Motloch et al. BTS 2017;2:

Heloise Mongue-Din et al. BTS 2017;2:

Type 1 immunity drives metabolic disease but protects against NAFLD

Proteasome Inhibition Attenuates Infarct Size and Preserves Cardiac Function in a Murine Model of Myocardial Ischemia-Reperfusion Injury William E. Stansfield,

Rena Watanabe et al. BTS 2016;1:

Stefano Toldo et al. BTS 2017;2:

Jason A. Bartos et al. BTS 2016;j.jacbts

Volume 93, Issue 1, (January 2018)

Helena M. Viola et al. BTS 2018;3:

Helena M. Viola et al. BTS 2018;3:

Volume 79, Issue 1, Pages (January 2011)

Dandan Wang et al. BTS 2018;3: Down-Regulation of miR-24 in Response to Insulin Infusion in Human Plasma Human plasma insulin (A), glucose (B),

Dandan Wang et al. BTS 2018;3: miR-24 Regulates OGT and ATG4A to Play Cardioprotective Effects Sequence alignment of miR-24 targeting sites on OGT.

PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice

Dandan Wang et al. BTS 2018;3: Cardiomyocyte-Specific Knock-In miR-24 Ameliorates Ischemia/Reperfusion Injury (A) Quantitative polymerase chain.

Cardiac Fibrosis at 18 Weeks Post TAC (A) Representative images (original magnification ×20) of Picrosirius red-stained cardiac tissue sections from HF +

Hironori Hara et al. BTS 2018;3:

Dandan Wang et al. BTS 2018;3: Diabetes Exacerbates Myocardial Infarction and Ischemia/Reperfusion Injury (A) Comparison of fasting blood glucose.

Brian R. Weil et al. BTS 2017;2: Experimental Protocol (A) Following baseline data collection, the left anterior descending coronary artery was.

Molecular Therapy - Nucleic Acids

Brian R. Weil et al. BTS 2017;2: Brief Myocardial Ischemia Produces Transient LV Dysfunction Consistent With Stunned Myocardium A 10-min total left.

Sven Y. Surikow et al. BTS 2018;3:

Renal Fibrosis and Plasma Creatinine Levels at 18 Weeks Post TAC (A) Plasma creatinine levels. (B) Representative images (original magnification ×20) of.

Prachi Umbarkar et al. BTS 2019;j.jacbts

Hironori Hara et al. BTS 2018;3:

Helena M. Viola et al. BTS 2018;3:

CD137/NFATc1 Axis Was Directly Targeted by miR-145 (A) Relative mRNA expression levels of NFATc1 and CD137 in the miR-145 mimic- or inhibitor-treated group.

Volume 19, Issue 4, Pages (April 2011)

Optimal dose and mode of delivery of Na+/H+ exchange-1 inhibitor are critical for reducing postsurgical ischemia-reperfusion injury Joel S Corvera, MD,

Sebastiano Sciarretta et al. JACC 2018;71:

Sebastiano Sciarretta et al. JACC 2018;71:

Nikole J. Byrne et al. BTS 2017;j.jacbts

Laura Z. Vanags et al. BTS 2018;3:

Cyp8b1−/− mice have improved islet insulin secretion and increased islet insulin content but unchanged β-cell mass. Cyp8b1−/− mice have improved islet.

BTG2 regulates gluconeogenic gene expression in diabetic mouse models

Overexpression of BTG2 resulted in an increase in hepatic gluconeogenesis. Overexpression of BTG2 resulted in an increase in hepatic gluconeogenesis. A:

Molecular Therapy - Nucleic Acids

TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin resistance. TG-CRP mice display fasting hyperglycemia, hyperinsulinemia, and insulin.

Volume 24, Issue 2, Pages (February 2016)

TXNIP and caspase-1 protein levels are increased in the adipose tissue of ob/ob mice. TXNIP and caspase-1 protein levels are increased in the adipose tissue.

Transgenic restoration of long-chain n-3 PUFA protects against obesity-linked insulin resistance and glucose intolerance. Transgenic restoration of long-chain.

Reduced OXPHOS expression and increased UCP expression.

Treatment of ob/ob mice with TTR-ASOs improves insulin sensitivity.

Effects of Rosi treatment on ASKO mice.

Expression of PKCδ in islets and other tissues of control and PKCδKN-overexpressing mice. Expression of PKCδ in islets and other tissues of control and.

Chronic rapamycin treatment impairs β-cell mass and insulin clearance in rats. Chronic rapamycin treatment impairs β-cell mass and insulin clearance in.

Effects of rhein on FBG (A) and glucose intolerance (B) in db/db mice.

Ju Youn Beak et al. BTS 2017;2:39-53

Céline Jumeau et al. BTS 2016;1:

Fig. 4 In vivo evaluation of insulin complex for type 1 diabetic mice treatment. In vivo evaluation of insulin complex for type 1 diabetic mice treatment.

Fig. 5 Effects of in vivo blockade of TLR9 on adipose tissue inflammation and insulin resistance in WT mice. Effects of in vivo blockade of TLR9 on adipose.

Presentation transcript:

Dandan Wang et al. BTS 2018;3:350-362 Overexpression of miR-24 Ameliorates Diabetic Ischemia/Reperfusion Injury (A) Schematic protocol of miR-24 delivery and I/R surgery. (B) Quantitative polymerase chain reaction analysis of miR-24 expression in hearts of db/db mice treated with mimic control (n = 6) or treated with miR-24 mimic (n = 6) for 2 weeks (normalized to U6). (C) Myocardial infarction size assessed following in vivo I/R (20 min LAD ligation and 3 h reperfusion) after treatment with miR-24 mimic (5 mg/kg) or scramble control intravenously, 2 weeks before LAD ligation. Representative images of myocardial tissue slices stained with Evans blue and triphenyl tetrazolium chloride. (D) Quantitation of infarct risk area. (E) Quantitation of infarct area expressed as percentage of the nonperfused risk area during coronary occlusion. (F) Enzyme-linked immunosorbent assay analysis of fasting plasma insulin levels in WT and db/db mice with without miR-24 mimic delivery (n = 8 to 10). (G) Fasting plasma glucose levels in db/db mice with without miR-24 mimic delivery (n = 10 to 12) (paired t test). Abbreviations as in Figure 1. Dandan Wang et al. BTS 2018;3:350-362 2018 The Authors